SEC Company Response from DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Feb 12, 2013
DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: Feb. 12, 2013 · CIK: 0001533998 · Accession: 0001144204-13-007893
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-186054
Letter
VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Attn: Amanda Ravitz Re: LabStyle Innovations Corp. Registration Statement on Form S-1, as amended File No. 333-186054
Dear Ms. Ravitz:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, LabStyle Innovations Corp. (the “Company”) hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. on Thursday, February 14, 2013, or as soon as thereafter practicable.
Please note that we acknowledge the following:
· should the Securities and Exchange Commission (the “Commission”) or the staff (the “Staff”), acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
· the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Very truly yours,
/s/ Oren Fuerst
Show Raw Text
CORRESP
1
filename1.htm
LabStyle Innovations Corp.
40 E. Main Street, Suite 759
Newark, Delaware 19711
February 12, 2013
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attn: Amanda Ravitz
Re: LabStyle Innovations Corp.
Registration Statement on Form S-1, as amended
File No. 333-186054
Dear Ms. Ravitz:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, LabStyle Innovations Corp. (the “Company”) hereby requests acceleration of effectiveness
of the above referenced Registration Statement so that it will become effective at 4:00 p.m. on Thursday, February 14, 2013, or
as soon as thereafter practicable.
Please note that we acknowledge the following:
· should the Securities and Exchange Commission (the “Commission”) or the staff (the “Staff”),
acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action
with respect to the filing;
· the action of the Commission or the Staff, acting pursuant to delegated authority, in declaring the filing effective, does
not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
· the Company may not assert Staff comments and the declaration of effectiveness as a defense in any proceeding initiated by
the Commission or any person under the federal securities laws of the United States.
Very truly yours,
/s/ Oren Fuerst
Oren Fuerst
Chief Executive Officer